MEEI drops litigation against QLT & Novartis

Article

Litigation proceedings initiated by the Massachusetts Eye and Ear Infirmary (MEEI) in 2001 against QLT and Novartis Ophthalmics, have been settled.

Litigation proceedings initiated by the Massachusetts Eye and Ear Infirmary (MEEI) in 2001 against QLT and Novartis Ophthalmics, have been settled.

Under the terms of the agreement, MEEI will dismiss its claim that QLT and Novatis had infringed US Patent #6,225,303 and QLT and Novartis will dismiss its counterclaims against MEEI and named MEEI researchers.

However, a further patent lawsuit, brought in 2000 by MEEI against QLT, has yet to be resolved.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.